Search

Your search keyword '"Propidium analogs & derivatives"' showing total 289 results

Search Constraints

Start Over You searched for: Descriptor "Propidium analogs & derivatives" Remove constraint Descriptor: "Propidium analogs & derivatives"
289 results on '"Propidium analogs & derivatives"'

Search Results

251. Rapid detection of viable salmonellae in produce by coupling propidium monoazide with loop-mediated isothermal amplification.

252. Propidium monoazide combined with real-time quantitative PCR underestimates heat-killed Listeria innocua.

253. Detection of viable Salmonella in lettuce by propidium monoazide real-time PCR.

254. Quantification of viable Legionella pneumophila cells using propidium monoazide combined with quantitative PCR.

255. [Evaluation of pathogen disinfection efficacy by chlorine and monochloramine disinfection based on quantitative PCR combined with propidium monoazide (PMA-qPCR)].

256. Comparison and characterization of microbial communities in sulfide-rich wastewater with and without propidium monoazide treatment.

257. Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.

258. Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide.

259. Determination of viable wine yeast using DNA binding dyes and quantitative PCR.

260. Determination of the effects of medium composition on the monochloramine disinfection kinetics of Nitrosomonas europaea by the propidium monoazide quantitative PCR and Live/Dead BacLight methods.

261. The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples.

262. Viability determination of Helicobacter pylori using propidium monoazide quantitative PCR.

263. Distinction between intact and antibiotic-inactivated bacteria by real-time PCR after treatment with propidium monoazide.

264. Discrimination of infectious bacteriophage T4 virus by propidium monoazide real-time PCR.

265. Rapid quantification of viable Campylobacter bacteria on chicken carcasses, using real-time PCR and propidium monoazide treatment, as a tool for quantitative risk assessment.

266. Rapid quantification of viable legionellae in water and biofilm using ethidium monoazide coupled with real-time quantitative PCR.

267. Mycobacterium avium subsp. paratuberculosis viability determination using F57 quantitative PCR in combination with propidium monoazide treatment.

268. Use of propidium monoazide in reverse transcriptase PCR to distinguish between infectious and noninfectious enteric viruses in water samples.

269. Discrimination between live and dead cellsin bacterial communities from environmental water samples analyzed by 454 pyrosequencing.

270. Comparison of ethidium monoazide and propidium monoazide for the selective detection of viable Legionella cells.

271. Method to detect only viable cells in microbial ecology.

272. Cryptosporidium propidium monoazide-PCR, a molecular biology-based technique for genotyping of viable Cryptosporidium oocysts.

273. Quantitative real-time PCR analysis of total and propidium monoazide-resistant fecal indicator bacteria in wastewater.

274. Rapid decay of host-specific fecal Bacteroidales cells in seawater as measured by quantitative PCR with propidium monoazide.

275. Quantification of live and dead probiotic bacteria in lyophilised product by real-time PCR and by flow cytometry.

276. Monochloramine disinfection kinetics of Nitrosomonas europaea by propidium monoazide quantitative PCR and Live/dead BacLight methods.

277. Improving clinical significance of PCR: use of propidium monoazide to distinguish viable from dead Staphylococcus aureus and Staphylococcus epidermidis.

278. Discrimination of viable and dead fecal Bacteroidales bacteria by quantitative PCR with propidium monoazide.

279. PCR-based method using propidium monoazide to distinguish viable from nonviable Bacillus subtilis spores.

280. Selective detection of live bacteria combining propidium monoazide sample treatment with microarray technology.

281. Novel approaches toward preferential detection of viable cells using nucleic acid amplification techniques.

282. A comparative study of the ability of EMA and PMA to distinguish viable from heat killed mixed bacterial flora from fish fillets.

283. Molecular monitoring of inactivation efficiencies of bacteria during pulsed electric field treatment of clinical wastewater.

284. Selective PCR detection of viable Enterobacter sakazakii cells utilizing propidium monoazide or ethidium bromide monoazide.

285. Quantifying fungal viability in air and water samples using quantitative PCR after treatment with propidium monoazide (PMA).

286. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.

287. Comparison of propidium monoazide with ethidium monoazide for differentiation of live vs. dead bacteria by selective removal of DNA from dead cells.

288. [Comparison of 2 techniques for measuring lymphocyte proliferation: tritiated methyl-thymidine incorporation and propidium iodide fluorometry].

289. Interaction of an organophosphate with a peripheral site on acetylcholinesterase.

Catalog

Books, media, physical & digital resources